$CTIC Up to date company activities and other impo

$CTIC Up to date company activities and other important information about $CTIC

$CTIC

DD Notes ~ http://www.ddnotesmaker.com/CTIC

##### recent news/filings ~ source: finance.yahoo.com

Tue, 01 Jul 2014 13:20:41 GMT ~ Tuesday’s Top Biotech Stories: CTI BioPharma, Agenus, and Salix Pharmaceuticals
read full: http://www.fool.com/investing/general/2014/07...lnk0000001
*********************************************************

Tue, 01 Jul 2014 10:05:20 GMT ~ CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis
- SEATTLE, July 1, 2014 /PRNewswire/ -- CTI BioPharma Corp. (CTI or the Company) (NASDAQ and MTA: CTIC) announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of ...
read full: http://www.noodls.com/view/447D073B3AF8DF46C9...793AD50E76
*********************************************************

Tue, 01 Jul 2014 05:56:00 GMT ~ 1:56 am CTI BioPharma completes recruitment in PERSIST-1 pivotal Phase 3 trial of Pacritinib for patients with myelofibrosis; expects to receive $20 mln development milestone payment from Baxter (BAX)
read full: http://finance.yahoo.com/news/inplay-briefing....html#ctic
*********************************************************

Tue, 01 Jul 2014 05:30:00 GMT ~ CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis
- SEATTLE, July 1, 2014 /PRNewswire/ -- CTI BioPharma Corp. (CTI or the Company) (NASDAQ and MTA: CTIC) announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis. Under the development and commercialization agreement for pacritinib with Baxter International, Inc. (Baxter), CTI expects to receive a $20 million development milestone payment in connection with the first treatment dosing of the last patient enrolled in PERSIST-1. CTI expects to achieve this milestone and receive payment by mid-third quarter 2014. "The PERSIST-1 clinical trial evaluating pacritinib, a novel JAK2/FLT3 inhibitor, is the most inclusive study of myelofibrosis patients seen in routine clinical practice to date," said Claire Harrison, M.D., Consultant Hematologist, Guy's and St. Thomas' NHS Foundation Trust, Guy's Hospital, London, United Kingdom and one of the principal investigators for PERSIST-1.
read full: http://finance.yahoo.com/news/cti-biopharma-c...00413.html
*********************************************************

Mon, 30 Jun 2014 20:54:58 GMT ~ CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Finan
read full: http://biz.yahoo.com/e/140630/ctic8-k.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=CTIC&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=CTIC&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CTIC/company-info
Ticker: $CTIC
OTC Market Place: Not Available
CIK code: 0000891293
Company name: CTI BioPharma Corp.
Company website: http://www.cticseattle.com
Incorporated In: WA, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CTIC/filings
Latest financials: http://www.otcmarkets.com/stock/CTIC/financials
Latest news: http://www.otcmarkets.com/stock/CTIC/news - http://finance.yahoo.com/q/h?s=CTIC+Headlines

Major holdings: http://data.cnbc.com/quotes/CTIC/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CTIC+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CTIC.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CTIC

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=CTI+BioPharma+Corp...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...harma+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.cticseattle.com
Alexa: http://www.alexa.com/siteinfo/http://www.cticseattle.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.cticseattle.com

Short Sales: http://www.otcmarkets.com/stock/CTIC/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/CTIC/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/CTIC/research
Historical Prices: http://finance.yahoo.com/q/hp?s=CTIC+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=CTIC+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=CTIC+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=CTIC+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=CTIC+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=CTIC+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=CTIC
Balance Sheet: http://finance.yahoo.com/q/bs?s=CTIC
Cash Flow: http://finance.yahoo.com/q/cf?s=CTIC+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/CTIC
Bloomberg: http://www.bloomberg.com/quote/CTIC:US
Morningstar: http://quotes.morningstar.com/stock/s?t=CTIC
Bussinessweek: http://investing.businessweek.com/research/st...icker=CTIC
Barchart: http://www.barchart.com/quotes/stocks/CTIC
OTC Short Report: http://otcshortreport.com/index.php?index=CTIC
Investopedia: http://www.investopedia.com/markets/stocks/CTIC/?wa=0

http://www.pennystocktweets.com/stocks/profile/CTIC

##### last known share structure ~ source: otcmarkets.com

Market Value: $421,022,657 a/o Jun 30, 2014
Shares Outstanding: 149,830,127 a/o Apr 23, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/CTIC